Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
Identifieur interne : 000172 ( PubMed/Corpus ); précédent : 000171; suivant : 000173Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
Auteurs : Michelle C. Crank ; John R. Mascola ; Barney S. GrahamSource :
- The Journal of infectious diseases [ 1537-6613 ] ; 2019.
English descriptors
- KwdEn :
- Animals, Antibodies, Viral (immunology), Antigens, Viral (genetics), Antigens, Viral (immunology), B-Lymphocytes (immunology), CD4-Positive T-Lymphocytes (immunology), CD8-Positive T-Lymphocytes (immunology), Disease Models, Animal, Gain of Function Mutation, Genetic Drift, Humans, Immunodominant Epitopes (immunology), Influenza A virus (genetics), Influenza A virus (immunology), Influenza A virus (isolation & purification), Influenza Vaccines (immunology), Influenza Vaccines (standards), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (transmission), Influenza, Human (virology), Orthomyxoviridae Infections (immunology), Orthomyxoviridae Infections (virology), Pandemics (prevention & control), Vaccines, Attenuated (immunology).
- MESH :
- chemical , genetics : Antigens, Viral.
- chemical , immunology : Antibodies, Viral, Antigens, Viral, Immunodominant Epitopes, Influenza Vaccines, Vaccines, Attenuated.
- epidemiology : Influenza, Human.
- genetics : Influenza A virus.
- immunology : B-Lymphocytes, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Influenza A virus, Orthomyxoviridae Infections.
- isolation & purification : Influenza A virus.
- prevention & control : Influenza, Human, Pandemics.
- chemical , standards : Influenza Vaccines.
- transmission : Influenza, Human.
- virology : Influenza, Human, Orthomyxoviridae Infections.
- Animals, Disease Models, Animal, Gain of Function Mutation, Genetic Drift, Humans.
DOI: 10.1093/infdis/jiz043
PubMed: 30715413
Links to Exploration step
pubmed:30715413Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.</title><author><name sortKey="Crank, Michelle C" sort="Crank, Michelle C" uniqKey="Crank M" first="Michelle C" last="Crank">Michelle C. Crank</name><affiliation><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation></affiliation></author><author><name sortKey="Mascola, John R" sort="Mascola, John R" uniqKey="Mascola J" first="John R" last="Mascola">John R. Mascola</name><affiliation><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation></affiliation></author><author><name sortKey="Graham, Barney S" sort="Graham, Barney S" uniqKey="Graham B" first="Barney S" last="Graham">Barney S. Graham</name><affiliation><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:30715413</idno><idno type="pmid">30715413</idno><idno type="doi">10.1093/infdis/jiz043</idno><idno type="wicri:Area/PubMed/Corpus">000172</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000172</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.</title><author><name sortKey="Crank, Michelle C" sort="Crank, Michelle C" uniqKey="Crank M" first="Michelle C" last="Crank">Michelle C. Crank</name><affiliation><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation></affiliation></author><author><name sortKey="Mascola, John R" sort="Mascola, John R" uniqKey="Mascola J" first="John R" last="Mascola">John R. Mascola</name><affiliation><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation></affiliation></author><author><name sortKey="Graham, Barney S" sort="Graham, Barney S" uniqKey="Graham B" first="Barney S" last="Graham">Barney S. Graham</name><affiliation><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The Journal of infectious diseases</title><idno type="eISSN">1537-6613</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Viral (immunology)</term><term>Antigens, Viral (genetics)</term><term>Antigens, Viral (immunology)</term><term>B-Lymphocytes (immunology)</term><term>CD4-Positive T-Lymphocytes (immunology)</term><term>CD8-Positive T-Lymphocytes (immunology)</term><term>Disease Models, Animal</term><term>Gain of Function Mutation</term><term>Genetic Drift</term><term>Humans</term><term>Immunodominant Epitopes (immunology)</term><term>Influenza A virus (genetics)</term><term>Influenza A virus (immunology)</term><term>Influenza A virus (isolation & purification)</term><term>Influenza Vaccines (immunology)</term><term>Influenza Vaccines (standards)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Influenza, Human (transmission)</term><term>Influenza, Human (virology)</term><term>Orthomyxoviridae Infections (immunology)</term><term>Orthomyxoviridae Infections (virology)</term><term>Pandemics (prevention & control)</term><term>Vaccines, Attenuated (immunology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term><term>Antigens, Viral</term><term>Immunodominant Epitopes</term><term>Influenza Vaccines</term><term>Vaccines, Attenuated</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>B-Lymphocytes</term><term>CD4-Positive T-Lymphocytes</term><term>CD8-Positive T-Lymphocytes</term><term>Influenza A virus</term><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pandemics</term></keywords><keywords scheme="MESH" type="chemical" qualifier="standards" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Disease Models, Animal</term><term>Gain of Function Mutation</term><term>Genetic Drift</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30715413</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>219</Volume><Issue>Suppl_1</Issue><PubDate><Year>2019</Year><Month>04</Month><Day>08</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.</ArticleTitle><Pagination><MedlinePgn>S107-S109</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiz043</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crank</LastName><ForeName>Michelle C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascola</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Barney S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016056">Immunodominant Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073659" MajorTopicYN="N">Gain of Function Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040961" MajorTopicYN="N">Genetic Drift</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016056" MajorTopicYN="N">Immunodominant Epitopes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Influenza</Keyword><Keyword MajorTopicYN="Y">Pandemic</Keyword><Keyword MajorTopicYN="Y">Vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30715413</ArticleId><ArticleId IdType="pii">5304928</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiz043</ArticleId><ArticleId IdType="pmc">PMC6452294</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2009 Sep;86(3):234-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19707212</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2013 Sep;255(1):230-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23947359</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2018 Jan;19(1):20-28</Citation><ArticleIdList><ArticleId IdType="pubmed">29199281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull World Health Organ. 2018 Feb 1;96(2):129-134</Citation><ArticleIdList><ArticleId IdType="pubmed">29403116</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2018 Jul 2;218(3):347-354</Citation><ArticleIdList><ArticleId IdType="pubmed">29506129</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2018 Apr 10;319(14):1431-1432</Citation><ArticleIdList><ArticleId IdType="pubmed">29566112</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S38-S45</Citation><ArticleIdList><ArticleId IdType="pubmed">30535315</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S97-S106</Citation><ArticleIdList><ArticleId IdType="pubmed">30715348</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S5-S13</Citation><ArticleIdList><ArticleId IdType="pubmed">30715352</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S62-S67</Citation><ArticleIdList><ArticleId IdType="pubmed">30715353</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S75-S80</Citation><ArticleIdList><ArticleId IdType="pubmed">30715357</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S88-S96</Citation><ArticleIdList><ArticleId IdType="pubmed">30715361</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S68-S74</Citation><ArticleIdList><ArticleId IdType="pubmed">30715367</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S14-S20</Citation><ArticleIdList><ArticleId IdType="pubmed">30715371</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S21-S29</Citation><ArticleIdList><ArticleId IdType="pubmed">30715373</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S30-S37</Citation><ArticleIdList><ArticleId IdType="pubmed">30715376</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S57-S61</Citation><ArticleIdList><ArticleId IdType="pubmed">30715379</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S81-S87</Citation><ArticleIdList><ArticleId IdType="pubmed">30715386</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S46-S56</Citation><ArticleIdList><ArticleId IdType="pubmed">30715467</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S1-S4</Citation><ArticleIdList><ArticleId IdType="pubmed">30715469</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000172 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000172 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:30715413
|texte= Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:30715413" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |